Posted on Tuesday, May 1st, 2012 at 2:09 pm.
Lumninex Corporation has now reported on their first quarter financial reports for 2012 and showed a 13 percent increase in revenue over the first quarter of 2011.
The consolidated revenue for the first quarter was reported at $48.7 million and the first quarter assay revenue was reported to be at $17.3 million. The operating expenses for the company also grown from the first quarter in 2012 compared to the first quarter in 2011.
This year, the operating expenses were at $28.2 million, over a $5 million increase over last year. Luminex develops biological testing technologies and they also manufacture them as well as market them for the life science industry. The CEO of Luminex stated that “Luminex delivered a solid financial and operating performance for the first quarter of 2012.”
If you or a loved one runs a business and would like to have experienced help to organize and manage your financial reports, contact the Austin Accountants today and discuss you situation.